BridgeBio Pharma Reports Third Quarter 2021 Financial Results and Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/29/2026
- S&P 500 ends lower; chips tumble and Moderna rallies
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
BridgeBio Pharma Inc. (BBIO) Misses Q3 EPS by 16c
November 4, 2021 7:37 AM EDTBridgeBio Pharma Inc. (NASDAQ: BBIO) reported Q3 EPS of ($1.06), $0.16 worse than the analyst estimate of ($0.90).
For earnings history and earnings-related data on BridgeBio Pharma Inc. (BBIO) click here.
... More